Sector pending / Medicinal Chemicals and Botanical ProductsUpdated 2026-05-10 22:07 UTC

BOM/544694 stock hub

BOM/544694 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BOM/544694is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

Bombay Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

BOM/544694

In the news

Latest news · BOM/544694

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/E30.3

P25 n/aP50 n/aP75 n/a

ROE24.8

P25 n/aP50 n/aP75 n/a

ROIC14.3

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BOM/544694 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

153

Groups with data

Currency

INR

Showing 153 of 153 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Enterprise value	INR 2.1B
Exchange	Bombay Stock Exchange
Financial currency	INR
First seen	2026-05-10
Industry	Medicinal Chemicals and Botanical Products
Last refreshed	2026-05-10
Market cap	INR 2B
Price	INR 283
Price currency	INR
Sic	2833
Symbol	bom/544694
Website	https://accretionnutraveda.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	2.47%
EV Earnings	41.01x
EV/EBIT	30.81x
EV/EBITDA	29.67x
EV/FCF	-8.66x
EV/Sales	6.16x
FCF yield	-11.72%
P/B ratio	5.78x
P/E ratio	30.27x
P/S ratio	6.08x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	20.01%
EBITDA Margin	20.78%
Gross margin	28.51%
Gross Profit	INR 96.1M
Gross Profit Growth	657.57%
Gross Profit Growth Q	48.16%
Net Income	INR 50.7M
Net Income Growth	1,706.24%
Net Income Growth Q	56.1%
Pretax Margin	18.42%
Profit Margin	15.03%
ROA	16.01
ROCE	17.18
ROE	24.83
ROIC	14.32
Roic5y	23.59

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS Growth	1,099.6
EPS Growth Q	-3.62
Revenue Growth	1,022.84x
Revenue Growth Q	81.07x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	INR 1.28
Assets	INR 417.9M
Cash	INR 12.8M
Current Assets	INR 362.3M
Current Liabilities	INR 25.4M
Debt	INR 42.3M
Debt EBITDA	INR 0.6
Debt Equity	INR 0.12
Debt FCF	INR -0.18
Equity	INR 354.7M
Interest Coverage	12.63
Liabilities	INR 63.2M
Long Term Assets	INR 55.7M
Long Term Liabilities	INR 37.8M
Net Cash	INR -29.5M
Net Cash By Market Cap	INR -1.44
Net Debt EBITDA	INR 0.42
Net Debt Equity	INR 0.08
Tangible Book Value	INR 354.7M
Tangible Book Value Per Share	INR 59.78

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	14.27
Inventory Turnover	3.55
Net Working Capital	INR 328.6M
Quick ratio	3.7
Working Capital	INR 336.9M
Working Capital Turnover	INR 1.75

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-50.57%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
50-day SMA	202.5
All Time High	300
All Time High Change	-9.43%
All Time High Date	2026-05-08
All Time Low	129
All Time Low Change	110.62%
All Time Low Date	2026-02-02
ATR	19.63
Beta1y	0.11
High	300
High52	300
High52 Date	2026-05-08
High52ch	-5.67%
Low	275.3
Low52	129
Low52 Date	2026-02-03
Low52ch	119.38%
Ma50ch	34.14%
RSI	77.54
RSI Monthly	0
RSI Weekly	0
Sharpe ratio	3.43x
Sortino ratio	11.7
Total Return	-50.57%
Tr1m	37.22%
Tr1w	4.5%
Tr3m	53.76%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	INR 67.5M
Operating Income Growth	1,438.3
Operating Income Growth Q	44.79
Operating margin	20.01

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,443,000%
Net Borrowing	3,695,000
Shares Insiders	73.48%
Shares Out	7,240,000
Shares Qo Q	0.41%
Shares Yo Y	50.57%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	INR -240.1M
Average Volume	19,000x
Bv Per Share	59.78
CAPEX	INR -845,000
Ch1m	37.22
Ch1w	4.5
Ch3m	53.76
Change	4.16%
Change From Open	-5.67
Close	271.7
Days Gap	10.42
Depreciation Amortization	2,603,000
Dollar Volume	2,830,000
Earnings Date	2026-05-08
EBIT	INR 67.5M
EBITDA	INR 70.1M
EPS	INR 9.35
F Score	4
FCF	INR -240.1M
FCF EV Yield	-11.55x
FCF Per Share	INR -33.16
Financing CF	252,695,000
Fiscal Year End	March
Founded	2,021
Graham Number	112.13921
Graham Upside	-60.37
Income Tax	INR 11.4M
Investing CF	-845,000
Is Primary Listing	1
Last Earnings Date	2026-05-08
Last Report Date	2026-03-31
Ma20	225.4
Ma20ch	20.52%
Net CF	12,604,000
Open	300
Position In Range	31.17
Ppne	16,563,000
Price Date	2026-05-08
Price EBITDA	INR 29.25
Ptbv Ratio	5.78
Relative Volume	0.53x
Revenue	337,155,000x
Tax By Revenue	3.39x
Tax Rate	18.4%
Volume	10,000

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does BOM/544694 pay a dividend?

Capital-return profile for this ticker.

Ownership

Who owns BOM/544694?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

+73.5%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+50.6%

Negative means the company is buying back shares.

Technical

BOM/544694 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

77.5

Above 70: short-term overbought

Price vs 200-day MA

n/a

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

3.43

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BOM/544694

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bom/544694 stock rating?

bom/544694 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bom/544694 analysis?

The full report lives at /stocks/bom/544694/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bom/544694?

The latest report frames bom/544694 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bom/544694 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.